# US 2019/0314313 A1 · Homeostatic regulation of l-dopa biosynthesis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314313 A1
- Document ID: US20190314313A1
- Status: Published application
- Kind: A1
- Application number: 16/341,222
- Filed: 2017-10-11
- Published: 2019-10-17
- Earliest claimed: 2016-10-11
- Assignees: Board of Regents, The University of Texas System
- Applicants: Board of Regents, the University of Texas System
- Inventors: Andrew D. Ellington; Ross Thyer
- Web page: https://patentgrep.com/patent/US20190314313A1

## CPC

- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- C12P 13/22: Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C07K 14/21: from Pseudomonadaceae (F)
- C12N 1/205: Bacterial isolates
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/78: for Pseudomonas
- C12P 13/06: Alanine; Leucine; Isoleucine; Serine; Homoserine
- C12N 2330/51: Specially adapted vectors
- C12N 2800/101: for bacteria
- C12R 2001/40: Pseudomonas putida
- C12Y 101/01049: Glucose-6-phosphate dehydrogenase (1.1.1.49)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12Y: ENZYMES

## Abstract

Disclosed herein are methods and compositions for the production of L-3,4-dihydroxyphenylalanine from a bacteria.

## Claims

### Claim 1

A genetically engineered cell capable of producing L-3,4-dihydroxyphenylalanine (L-DOPA), wherein said cell comprises a gene encoding PP2551 of Pseudomonas putida.

### Claim 2 (depends on 1)

The cell of claim 1, wherein an amino acid sequence encoded by PP2251 of Pseudomonas putida comprises SEQ ID NO: 1.

### Claim 3 (depends on 1)

The cell of claim 1, further comprising a promoter recognized by PP2251.

### Claim 4 (depends on 3)

The cell of claim 3, wherein the promoter recognized by PP2251 comprises SEQ ID NO: 2.

### Claim 5 (depends on 1)

The cell of claim 1, wherein the cell further comprises genes hpaB and hpaC encoding HpaB and HpaC respectively.

### Claim 6 (depends on 5)

The cell of claim 5, wherein the amino acid sequence encoded by hpaB is SEQ ID NO: 3.

### Claim 7 (depends on 5)

The cell of claim 5, wherein the amino acid sequence encoded by hpaC is SEQ ID NO: 4.

### Claim 8 (depends on 1)

The cell of claim 1, wherein the cell is capable of producing L-DOPA at a steady state.

### Claim 9 (depends on 1)

The cell of claim 1, wherein transcriptional regulator tyrosine repressor (tyrR) has been deleted.

### Claim 10 (depends on 1)

The cell of claim 1, wherein transcriptional regulator carbon storage regulator A (csrA) has been deleted.

### Claim 11 (depends on 1)

The cell of claim 1, wherein glucose transport system of the bacterium has been altered from phosphotransferase system (PTS) to ATP-dependent uptake.

### Claim 12 (depends on 1)

The cell of claim 1, wherein phosphorylation system of the cell has been altered to overexpress galactose permease gene (galP) and glucokinase gene (glk).

### Claim 13 (depends on 1)

The cell of claim 1, wherein glucose-6-phosphate dehydrogenase gene (zwf) and prephenate dehydratase and its leader peptide genes (pheLA) have been knocked out.

### Claim 14 (depends on 1)

The cell of claim 1, wherein a fusion protein chimera of a downstream pathway of chorismate has been integrated.

### Claim 15

A plasmid comprising a gene encoding PP2551 of Pseudomonas putida, a promoter thereof, and genes encoding hpaB and hpaC.

### Claim 16 (depends on 16)

A cell line comprising the plasmid of claim 16.

### Claim 17

A method of producing L-DOPA, comprising transforming a cell with a gene encoding PP2551 of Pseudomonas putida.

### Claim 18 (depends on 17)

The method of claim 17, wherein an amino acid sequence encoded by PP2251 of Pseudomonas putida comprises SEQ ID NO: 1.

### Claim 19 (depends on 17)

The method of claim 17, further comprising a promoter recognized by PP2251.

### Claim 20 (depends on 19)

The method of claim 19, wherein the promoter recognized by PP2251 comprises SEQ ID NO: 2.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23

(canceled)
